Efficacy and safety profiles of dolutegravir plus lamivudine vs . bictegravir/emtricitabine/tenofovir alafenamide in therapy-naïve adults with HIV-1.

Wei, Yinghua; Li, Jin; Xu, Ruhong; Wen, Li; Deng, Yiming; He, Lixia; Zhong, Huijun; Wang, Yanhao

Wei, Yinghua; Li, Jin; Xu, Ruhong; Wen, Li; Deng, Yiming; He, Lixia; Zhong, Huijun; Wang, Yanhao.

Affiliation

Wei Y; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Li J; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, Guangdong 523000, China.
Xu R; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, Guangdong 523000, China.
Wen L; Center for Disease Control and Prevention of Jiulongpo District, Chongqing 400050, China.
Deng Y; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
He L; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Zhong H; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, Guangdong 523000, China.
Wang Y; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, Guangdong 523000, China.

Chin Med J (Engl) ; 136(22): 2677-2685, 2023 Nov 20.

Article de En | MEDLINE | ID: mdl-37914678

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Agents antiVIH Limites: Adult / Humans Pays/Région comme sujet: Asia Langue: En Journal: Chin Med J (Engl) Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google